Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Lower Extremity Spasticity in MS
NCT03585569Phase 3Unknown
- Sponsor
- Neurology Center of New England
- Start
- May 2018
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Neurology Center of New England. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT03585569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585569.